Allscripts Healthcare Solutions Investor Presentation — January 2021

Document content

Allscripts Healthcare

J.P. Morgan Virtual Healthcare Conference| January 2021© 2021 Allscripts Healthcare, LLC and/or its affiliates. 2

This presentation contains forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These forward -looking statements, including

the preliminary financial information included in this presentation, are based on the current beliefs and expectations of All scripts management, only speak as of the date that

they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words s uchas “future,” “anticipates,” “believes,”

“estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual res ults could differ significantly from those set forth in

the forward -looking statements and reported results should not be considered an indication of future performance. Certain factor s that could cause Allscripts actual results to

differ materially from those described in the forward -looking statements include, but are not limited to: our use of the proceed s from the sale of our EPSibusiness and

CarePort Health business; our ability to achieve the margin targets associated with our margin improvement initiatives within the cont emplated time periods, if at all; risks

relevant to our share repurchase program, such as general market conditions, fluctuations in the price of our common stock or changes in our liquidity or capital allocation

strategies; the magnitude, severity and duration of the COVID -19 pandemic, including the impacts of the pandemic on our business , our employees, our clients and our

suppliers; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including deni al-of-services, ransomware or other Internet -based

attacks; the failure by Practice Fusion to comply with the terms of its settlement agreements with the U.S. Department of Jus tice (the “DOJ”); the costs and burdens of

compliance by Practice Fusion with the terms of its settlement agreements with the DOJ; additional investigations and proceed ings from governmental entities or third parties

other than the DOJ related to the same or similar conduct underlying the DOJ’s investigations into Practice Fusion’s business practices; changes in interoperability or other

regulatory standards; the expected financial results of businesses acquired by us; the successful integration of businesses a cquired by us; the anticipated and unanticipated

expenses and liabilities related to businesses acquired by us, including the civil investigation by the U.S. Attorney’s Offic e involving our EIS business; Allscripts ability to